Network Meta-Analysis [NMA] is now a widely accepted approach for comparitive efficacy research. As well as providing a brief introduction to NMA, here we summarise some of the main criticisms of NMAs submitted by manufacturers to Health Technology Assessment bodies. We also list the key appraisal tools used to access the quality of NMAs.
Link to Evidence Note